Study Design
non-affective psychosis
ADVERSE EVENTS, CROSS
A 4-arm multi-center, single-blinded, adaptive, randomized controlled trial comparing 3 CR implementation methods compared to treatment-as-usual (TAU) in people presenting with non-affective psychosis in UK NHS EIS. Outcomes were measured at weeks 0, 15, and 39. Treatment was provided independently (at home with phone contact and drop-in clinics), in groups or one-to-one within a 12-week time window. Camden and Kings Cross NHS Research Ethics Committee (ref. number 15/LO/1960) provided a favorable review. An Independent Data Monitoring Committee (IDMC) oversaw study progression, adverse events, and statistical analyses.